MeSH D003389 - cranial nerve diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D003389:
Cranial nerve diseases
0 Companies
0 Drugs
Success rate
D000160:Vestibulocochlear nerve diseases
0 Companies
0 Drugs
Success rate
D003390:Cranial nerve neoplasms
0 Companies
0 Drugs
Success rate
D005155:Facial nerve diseases
0 Companies
0 Drugs
Success rate
D009901:Optic nerve diseases
0 Companies
0 Drugs
Success rate
D015835:Ocular motility disorders
0 Companies
0 Drugs
Success rate
D020209:Cranial nerve injuries
0 Companies
0 Drugs
Success rate
D020421:Vagus nerve diseases
0 Companies
0 Drugs
Success rate
D020431:Olfactory nerve diseases
0 Companies
0 Drugs
Success rate
D020432:Trochlear nerve diseases
0 Companies
0 Drugs
Success rate
D020434:Abducens nerve diseases
0 Companies
0 Drugs
Success rate
D020435:Glossopharyngeal nerve diseases
0 Companies
0 Drugs
Success rate
D020436:Accessory nerve diseases
0 Companies
0 Drugs
Success rate
D020437:Hypoglossal nerve diseases
0 Companies
0 Drugs
Success rate
D060486:Ophthalmoplegic migraine
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%5/5
Phase 2
0%0/6
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use